Research chemical merchant accounts UK

Research chemicals are a blanket decline at mainstream UK acquirers. The category covers peptides, SARMs, nootropic compounds and laboratory reagents, and card schemes apply their highest-risk treatment because of regulatory uncertainty and chargeback exposure. Stripe, PayPal, SumUp and the high-street acquirers reject or terminate on review, so sellers route through specialist acquirers that underwrite research-use-only catalogues case-by-case, at high rates and substantial reserves. Compliance hinges on labelling and the complete absence of human-use claims.

Legal status (UK)

Lawful to sell as research reagents with correct labelling and, where relevant, compliance with the Psychoactive Substances Act 2016 and controlled-substance schedules. Presenting any product for human consumption removes the research-chemical defence and can constitute supply of an unlicensed medicine or a controlled or psychoactive substance.

Best way to take Research chemical payments (UK)

Our pick

MerchantHQ, specialist Research chemical broker and account team

Mainstream UK acquirers (SumUp, Square, Zettle, Dojo, Worldpay, Barclaycard) decline Research chemical at onboarding or terminate after launch. We hold a specialist panel of UK high-risk acquirers that underwrite it. As a broker we match you to the right one for your licence, volume and processing history, then stay on as your named UK account team for the life of the agreement.

The acquirer pays our commission on signup, so it costs you nothing on top, and we never sell your details on. We disclose the risk classification upfront so the right underwriter is approached from the start.

Get matched to a Research chemical acquirer

High-risk merchants are the most exposed to chargebacks, frozen funds and MATCH/TMF listings, and that is exactly what your MerchantHQ account team handles, for the life of the agreement.

How Research chemical placements work

Research chemical routes to specialist regulated-vertical acquirers matched per application rather than a published list. The right underwriter depends on your licence, volume and sub-category, so we approach it individually. We hold the relationships and disclose your risk classification upfront so the right acquirer is contacted from the start.

Typical pricing

Rate
4.0% to 6.5% blended
Settlement reserve
10% to 25% rolling reserve common

Watch outs

  • Every product must be labelled not for human consumption with research-use-only terms; human-use framing forfeits the legal defence.
  • Check each compound against controlled-substance schedules and the Psychoactive Substances Act 2016 before listing.
  • No dosing, consumption or therapeutic guidance anywhere on the site.
  • Underwriters review your full catalogue; a single non-compliant SKU can sink the application or trigger termination.
OM

Oliver Mackman

Director, MerchantHQ

Oliver leads MerchantHQ's terminal testing and acquirer comparison. With a background in UK commercial finance and merchant payments, he oversees terminal reviews, switching guidance and high-risk vertical mapping.

Last reviewed: 3 June 2026